Steven O’Day - Researcher Profile | RDL Research Database

Publications

2 shown

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi , Steven O’Day , David F. McDermott +26 more

Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma. Adverse eve...

2010 New England Journal of Medicine 14794 citations

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Antoni Ribas , Igor Puzanov , Reinhard Dummer +33 more

2015 The Lancet Oncology 1528 citations

Frequent Co-Authors

F. Stephen Hodi

Dana-Farber Cancer Institute

David F. McDermott

American Society of Clinical Oncology

Robert Weber

Researcher Info

h-index: 2
Publications: 2
Citations: 16,322
Institution: Angeles Clinic and Research Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0009-0005-5345-5417

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.